7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.5.1
Liraglutide
Victoza, Saxenda
Removed from Cat 2

Status is in flux. FDA review activity is ongoing, check before you commit.

Talk to a licensed clinician before acting on this.

FDA-approved GLP-1 drug; still in shortage, 503B exclusion proposed but not final

Metabolic

Same category

Related peptides

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.